# Adjuvant Aspirin Treatment for Colon Cancer Patients

> **NCT02467582** · PHASE3 · TERMINATED · sponsor: **Swiss Cancer Institute** · enrollment: 1040 (actual)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02467582
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06-09
- **Primary completion:** 2023-09-14
- **Final completion:** 2023-09-14
- **Target enrollment:** 1040 (ACTUAL)
- **Why stopped:** Board decision in 2020 due to lack of financial funding.
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02467582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02467582, "Adjuvant Aspirin Treatment for Colon Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02467582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*